
table of contents ![]() High purity of tumour samples is a necessity for accurate genetic and … '); |
Biology Articles » Biotechnology » Red Biotechnology » Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail » Table 1
Table 1
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Comparison of the discussed four different enrichment approaches |
||||
| DGC |
RS+DGC |
DGC+MCS |
DGC+FACS |
|
|
|
||||
| Purity |
ca. 70% a |
ca. 93% a |
> 98% d |
90 – 95% f |
| CD5+/CD19+ |
CD5+/CD19+ |
> 93% e |
CD5+/CD19+ |
|
| CD19+ |
||||
| 86% (± 14%) b |
||||
| CD19+ |
||||
| 90% (± 7%) c |
||||
| CD5+/CD19+/CD23+ |
||||
| Time of procedure |
< 60 mins. |
< 90 mins. |
> 120 mins (increasing with sample volume) |
> 120 mins (increasing with sample volume) |
| Selection method |
negative |
negative |
positive |
positive |
| Limitations |
highly depending on WBC count |
dependent on WBC count when < 20 × 106 cells/ml PB |
long process time and expensive |
long process time and very expensive |
| cost |
low |
medium |
medium-high |
high |
| Required Infra-structure |
centrifuge |
centrifuge |
centrifuge + MCS Sorter |
centrifuge + FACS sorter |
|
|
||||
|
DGC: density gradient centrifugation, RS+DGC: RosetteSep incubation prior to DGC, DGC+MCS: DGC and subsequent magnetic cell sorting, DGC+FACS: DGC and subsequent fluorescent activated cell sorting. a average purity experienced in our study b purity reported by Haslinger et al., 2004 c purity reported by Falt et al., 2005 d purity reported by Rosenwald et al., 2004 and Wiestner et al., 2003 e Huttman et al., 2006 f purity reported by Stankovic et al., 2004 |
||||
rating: 2.00 from 1 votes | updated on: 29 Nov 2008 | views: 3644 |
© Biology-Online.org. All Rights Reserved. Register | Login | About Us | Contact Us | Link to Us | Disclaimer & Privacy